Skip to main content
Clinical Trials/IRCT20100228003449N31
IRCT20100228003449N31
Recruiting
Phase 2

Comparing efficacy and safety of different doses of dexamethasone in hospitalized patients with COVID-19

Tehran University of Medical Sciences0 sites119 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
COVID-19 pneumonia.
Sponsor
Tehran University of Medical Sciences
Enrollment
119
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult patients (18\-85 years old)
  • With diagnose of COVID\-19 according to laboratory, clinical or radiological findings
  • With indication for hospitalization

Exclusion Criteria

  • Contraindication of corticosteroids (uncontrolled diabetes mellitus, active bacteria, fungal or parasite infections, hypersensitivity reactions, close angle glaucoma, uncontrolled neuropsychiatric disorders, unstable cardiovascular disorders including acute myocardial infarction, acute thrombosis, uncontrolled hypertension, viral hepatitis, history of corticosteroids induced myopathy)
  • History of recent corticosteroids or other immunosuppressant drugs use

Outcomes

Primary Outcomes

Not specified

Similar Trials